EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.22.B75 | (di-SUMO-2)-Ran GTPase-activating protein 1 conjugate + H2O |
SENP7 displays isopeptidase activity against di-SUMO-2- and SUMO-2-modified Ran GTPase-activating protein 1 but has limited activity against SUMO-1-modified Ran GTPase-activating protein 1 |
Homo sapiens |
? |
- |
? |
3.4.22.B75 | (K335, K372, K382)-triSUMOyl-cyclic GMP-AMP synthase + 3 H2O |
SUMO is conjugated onto the lysine residues 335, 372 and 382. SENP7 reverses this inhibition via catalyzing the deSUMOylation |
Homo sapiens |
3 SUMO + cyclic GMP-AMP synthase |
- |
? |
3.4.22.B75 | (SUMO-2)-Ran GTPase-activating protein 1 conjugate + H2O |
SENP7 displays isopeptidase activity against di-SUMO-2- and SUMO-2-modified Ran GTPase-activating protein 1 but has limited activity against SUMO-1-modified Ran GTPase-activating protein 1 |
Homo sapiens |
? |
- |
? |
3.4.22.B75 | (SUMO-3)-Ran GTPase-activating protein 1 conjugate + H2O |
SENP6 and SENP7 prefer SUMO2 or SUMO3 in deconjugation reactions with rates comparable with those catalyzed by SENP2. In contrast to SENP2, SENP6 and SENP7 are less able to deconjugate SUMO1-RanGAP1, and products are only detected at enzyme concentrations 100 x higher than that observed for reactions containing SENP2 |
Homo sapiens |
SUMO-3 + Ran GTPase-activating protein 1 |
- |
? |
3.4.22.B75 | acetyl-LRGG-7-amido-4-trifluoromethylcoumarin + H2O |
SENP7 prefers the LRGG sequence, residues typical of Nedd8 or ubiquitin in the P3 and P4 positions |
Homo sapiens |
acetyl-LRGG + 7-amino-4-trifluoromethylcoumarin |
- |
? |
3.4.22.B75 | acetyl-QTGG-7-amido-4-trifluoromethylcoumarin + H2O |
very low activity |
Homo sapiens |
acetyl-QTGG + 7-amino-4-trifluoromethylcoumarin |
- |
? |
3.4.22.B75 | axin1 + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.B75 | di-SUMO-2 + H2O |
- |
Homo sapiens |
2 SUMO-2 |
- |
? |
3.4.22.B75 | di-SUMO-3 + H2O |
- |
Homo sapiens |
2 SUMO-3 |
- |
? |
3.4.22.B75 | more |
SENP7 has a restricted substrate specificity, being unable to process SUMO precursors and displaying paralogue-specific isopeptidase activity |
Homo sapiens |
? |
- |
? |